preoperative radiation therapy

RADIATION2 trials

Sponsors

National Cancer Institute, Naples, Maria Sklodowska-Curie National Research Institute of Oncology

Conditions

Breast CancerColorectal Cancer

Phase 1

Preoperative Valproic Acid and Radiation Therapy for Rectal Cancer

National Cancer Institute, NaplesColorectal Cancer

Start: 2012-05-31End: 2024-04-30Target: 152Updated: 2023-03-24

Phase 2

Preoperative Immunotherapy Combined With Stereotactic Radiation Therapy Boost in the Treatment of HER2-negative Breast Cancer

RecruitingNCT06472583

Maria Sklodowska-Curie National Research Institute of OncologyBreast Cancer

Start: 2024-04-11End: 2028-02-28Target: 78Updated: 2024-06-25

Related Papers

Abstract 2453: Valproic acid enhances immune reprogramming in locally advanced rectal cancer: Insights from the VshoRTR3 trial

Cancer Research2026-04-03

Phase I/II study of valproic acid (VPA) and short-course radiotherapy (SCRT) plus capecitabine (CAP) as preoperative treatment in low-moderate risk rectal cancer (V-shoRT-R3)

Annals of Oncology2018-10-015 citations

Abstract 2569: Synergistic antitumor interaction between valproic acid, capecitabine and radiotherapy in colorectal cancer as a rationale for the innovative V-shoRT-R3 trial in locally advanced rectal cancer patients

Cancer Research2015-08-01

Phase 1/2 study of valproic acid and short-course radiotherapy plus capecitabine as preoperative treatment in low-moderate risk rectal cancer-V-shoRT-R3 (Valproic acid--short Radiotherapy--rectum 3rd trial).

2014-11-2430 citations